Medical & Clinical Research Associates

Bay Shore, New York 11706

0 studies enrolling now · 5 studies all time

What they study most

Benign Prostatic Hypertrophy, Nocturia, Prostate Cancer, Prostatic Intraepithelial Neoplasia

Studies at this site

• Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) — Stopped early
• A Study of Degarelix in Patients With Prostate Cancer — Completed
• Efficacy Study of VA106483 in Males With Nocturia. — Completed
• A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN) — Completed
• Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) — Completed